- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00716872
Improving the Sleep of Cancer Patients Using an Internet-Based Program (SHUTi-C)
24. februar 2010 oppdatert av: University of Virginia
Evaluating Internet-Based Interventions for Insomnia in Cancer Patients
The purpose of this study is to determine whether an Internet-based program, Sleep Healthy Using the Internet (SHUTi, or "Shut-Eye"), can help to improve the sleep of people who are in remission from cancer and experiencing symptoms of insomnia.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The purpose of this study is to test the feasibility of using an Internet program to improve the sleep of cancer patients with insomnia.
Participants will receive access to the Internet program (called SHUTi, or "Shut-Eye") as well as to self-hypnosis recordings designed to improve sleep.
SHUTi provides an online, tailored educational program to individuals who are experiencing sleep difficulties, including those having difficulty falling asleep, waking in the middle of the night, and waking too early in the morning.
Studietype
Intervensjonell
Registrering (Forventet)
22
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Virginia
-
Charlottesville, Virginia, Forente stater, 22908
- University of Virginia Department of Psychiatry & Neurobehavioral Sciences
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
21 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- Age = At least 21 years old
- Regular access to the Internet, including e-mail
Cancer patient
- Any type of cancer (EXCEPT non-melanoma skin cancer)
- In remission from any stage of cancer (active treatment completed at least one month prior to enrollment)
Insomnia diagnosis (combined from DSM-IV and ICSD):
- Subjective complaints of poor sleep for at least 6 months
- Sleep difficulties ≥3 nights/week
- Difficulty falling asleep (≥30 minutes to fall asleep) OR
Difficulty staying asleep (≥30 minutes awake in the middle of the night)
- ≤6.5 hours sleep/night
- Poor sleep causes marked distress or significant impairment in daytime functioning (e.g. fatigue, performance deficits, mood disturbance)
- Participant feels that the insomnia was caused/aggravated by cancer or cancer treatment
Exclusion Criteria:
- Having a sleep disorder other than insomnia (e.g. sleep apnea, RLS, narcolepsy, parasomnias)
- Having a medical condition other than cancer that causes insomnia
- Experiencing a psychiatric disturbance (major depression, psychosis)
- Experiencing substance abuse
- Currently undergoing psychotherapy or counseling
- Changing sleep/anxiety/depression medication within the past month
Having an "unusual" sleep pattern
- Normal bedtime is after 2am OR
- Normal wake time is after 9am
- Working as a shift worker (that is, having a schedule that requires working through the night)
- Participants reports that she is pregnant or intending to get pregnant in the next 4 months
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: ImmedSHUTi/ImmedHyp
In the first part of the trial, participants are assigned to the Immediate SHUTi group; that is, they receive access to the SHUTi program right away.
In the second part of the trial (3 months later), participants are assigned to the Immediate Hypnosis group; that is, they receive access to the Hypnosis recordings right away.
|
SHUTi is an Internet program based on cognitive-behavioral therapy for insomnia (CBT-I).
Users complete daily online sleep diaries in addition to receiving weekly access to six interactive "Cores" of information.
As they progress through the program, users receive tailored instructions for how to improve their sleep.
Subjects listen to self-hypnosis recordings designed to improve their disturbed sleep.
|
|
Eksperimentell: ImmedSHUTi/DelayHyp
In the first part of the trial, participants are assigned to the Immediate SHUTi group; that is, they receive access to the SHUTi program right away.
In the second part of the trial (3 months later), participants are assigned to the Delayed Hypnosis group; that is, they receive access to the Hypnosis recordings at the end of the study.
|
SHUTi is an Internet program based on cognitive-behavioral therapy for insomnia (CBT-I).
Users complete daily online sleep diaries in addition to receiving weekly access to six interactive "Cores" of information.
As they progress through the program, users receive tailored instructions for how to improve their sleep.
|
|
Eksperimentell: DelaySHUTi/ImmedHyp
In the first part of the trial, participants are assigned to the Delayed SHUTi group; that is, they receive access to the SHUTi program at the end of the study.
In the second part of the trial (3 months later), participants are assigned to the Immediate Hypnosis group; that is, they receive access to the Hypnosis recordings right away.
|
Subjects listen to self-hypnosis recordings designed to improve their disturbed sleep.
|
|
Ingen inngripen: DelaySHUTi/DelayHyp
In the first part of the trial, participants are assigned to the Delayed SHUTi group; that is, they receive access to the SHUTi program at the end of the study.
In the second part of the trial (3 months later), participants are assigned to the Delayed Hypnosis group; that is, they receive access to the Hypnosis recordings at the end of the study.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Insomnia Severity Index (ISI)
Tidsramme: prior to intervention, after SHUTi use, after Hypnosis use
|
prior to intervention, after SHUTi use, after Hypnosis use
|
|
Sleep Diary: Sleep Efficiency
Tidsramme: prior to intervention, after SHUTi use, after Hypnosis use
|
prior to intervention, after SHUTi use, after Hypnosis use
|
|
Sleep Diary: Total Sleep Time
Tidsramme: prior to intervention, after SHUTi use, after Hypnosis use
|
prior to intervention, after SHUTi use, after Hypnosis use
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Sleep Diary: Sleep Onset Latency (SOL)
Tidsramme: prior to intervention, after SHUTi use, after Hypnosis use
|
prior to intervention, after SHUTi use, after Hypnosis use
|
|
Sleep Diary: Wake After Sleep Onset (WASO)
Tidsramme: prior to intervention, after SHUTi use, after Hypnosis use
|
prior to intervention, after SHUTi use, after Hypnosis use
|
|
Sleep Diary: Number of Nighttime Awakenings
Tidsramme: prior to intervention, after SHUTi use, after Hypnosis use
|
prior to intervention, after SHUTi use, after Hypnosis use
|
|
Hospital Depression and Anxiety Scale
Tidsramme: prior to intervention, after SHUTi use, after Hypnosis use
|
prior to intervention, after SHUTi use, after Hypnosis use
|
|
Pain scale
Tidsramme: prior to intervention, after SHUTi use, after Hypnosis use
|
prior to intervention, after SHUTi use, after Hypnosis use
|
|
Multidimensional Fatigue Symptom Inventory
Tidsramme: prior to intervention, after SHUTi use, after Hypnosis use
|
prior to intervention, after SHUTi use, after Hypnosis use
|
|
Quality of Life (SF-12 Health Survey)
Tidsramme: prior to intervention, after SHUTi use, after Hypnosis use
|
prior to intervention, after SHUTi use, after Hypnosis use
|
|
Hot flashes
Tidsramme: prior to intervention, after SHUTi use, after Hypnosis use
|
prior to intervention, after SHUTi use, after Hypnosis use
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Hovedetterforsker: Lee M Ritterband, Ph.D., University of Virginia
- Hovedetterforsker: Lora D Baum, Ph.D., University of Virginia
- Studieleder: Elaine T Bailey, Ph.D., University of Virginia
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Hjelpsomme linker
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. juli 2008
Primær fullføring (Faktiske)
1. november 2009
Studiet fullført (Faktiske)
1. november 2009
Datoer for studieregistrering
Først innsendt
18. juni 2008
Først innsendt som oppfylte QC-kriteriene
14. juli 2008
Først lagt ut (Anslag)
16. juli 2008
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
25. februar 2010
Siste oppdatering sendt inn som oppfylte QC-kriteriene
24. februar 2010
Sist bekreftet
1. februar 2010
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 13685
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .